Discontinuation report ZANTAC
| Report ID | 22617 |
| Drug Identification Number | 02212366 |
| Brand name | ZANTAC |
| Common or Proper name | Ranitidine injection |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | RANITIDINE |
| Strength(s) | 25MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | All pack sizes / Tous les formats |
| ATC code | A02BA |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2018-08-31 |
| Remaining supply date | 2018-11-14 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2018-09-24 | French | Compare |
| v6 | 2018-09-24 | English | Compare |
| v5 | 2018-09-01 | English | Compare |
| v4 | 2018-08-31 | French | Compare |
| v3 | 2018-08-31 | English | Compare |
| v2 | 2017-09-19 | French | Compare |
| v1 | 2017-09-19 | English | Compare |
Showing 1 to 7 of 7